YULIANI, S. H. (2021). NANOPARTICLE AS THE STRATEGY FOR THE DEVELOPMENT OF SARS-COV-2 ANTIVIRAL DRUGS. International Journal of Applied Pharmaceutics, 13(5), 33–43. https://doi.org/10.22159/ijap.2021v13i5.42604